Cargando…
Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors
The clinical severity and annual occurrence of influenza virus epidemics, combined with the availability of just a single class of antivirals to treat infections, underscores the urgent need to develop new anti-influenza drugs. The endonuclease activity within the viral acidic polymerase (PA) protei...
Autores principales: | Jones, Jeremy C., Kumar, Gyanendra, Barman, Subrata, Najera, Isabel, White, Stephen W., Webby, Richard J., Govorkova, Elena A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915737/ https://www.ncbi.nlm.nih.gov/pubmed/29691337 http://dx.doi.org/10.1128/mBio.00430-18 |
Ejemplares similares
-
Author Correction for Jones et al., “Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors”
por: Jones, Jeremy C., et al.
Publicado: (2018) -
Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease
por: DuBois, Rebecca M., et al.
Publicado: (2012) -
N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes
por: Carcelli, Mauro, et al.
Publicado: (2016) -
Structural insights into the substrate specificity of the endonuclease activity of the influenza virus cap-snatching mechanism
por: Kumar, Gyanendra, et al.
Publicado: (2021) -
Influenza A virus polymerase acidic protein E23G/K substitutions weaken key baloxavir drug-binding contacts with minimal impact on replication and transmission
por: Jones, Jeremy C., et al.
Publicado: (2022)